PARP1-Erk synergism in proliferating cells

Leonid Visochek; Malka Cohen-Armon

doi:10.18632/oncotarget.25633

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

PARP1-Erk synergism in proliferating cells

Leonid Visochek and Malka Cohen-Armon _

PDF | HTML | How to cite

Oncotarget. 2018; 9:29140-29145. https://doi.org/10.18632/oncotarget.25633

Metrics: PDF 1977 views | HTML 2299 views | ?

Abstract

Leonid Visochek1 and Malka Cohen-Armon1,2

1Department of Physiology and Pharmacology, Sackler School of Medicine, Tel-Aviv University, Tel Aviv 69978, Israel

2Sagol School of Neuroscience, Tel-Aviv University, Tel Aviv 69978, Israel

Correspondence to:

Malka Cohen-Armon, email: [email protected]

Keywords: PARP1-Erk binding; PARP1-dependent Erk activity; c-Fos; Mouse embryonic fibroblasts

Received: May 27, 2018 Accepted: May 31, 2018 Published: June 26, 2018

ABSTRACT

A synergism between PARP1 and phosphorylated Erk mediating IEG (immediate early gene) expression has been recently reported in cerebral neurons and cardiomyocytes. Stimulation induced PARP-Erk synergism was required for IEG expression underlying synaptic plasticity and long-term memory acquisition during learning. It was similarly required for cardiomyocytes development. Here, we identified this mechanism in Erk-induced gene expression promoting proliferation. This mechanism can be targeted in malignant cells.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25633

Publication Alerts

Research Papers:

PARP1-Erk synergism in proliferating cells

Abstract